Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes

被引:10
作者
Laffel, L [1 ]
机构
[1] Harvard Univ, Sch Med, Joslin Clin, Boston, MA 02215 USA
关键词
acetoacetate; beta-hydroxybutyrate; diabetes; diabetic ketoacidosis; ketone bodies;
D O I
10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ketone bodies are produced by the liver and used peripherally as an energy source when glucose is not readily available. The two main ketone bodies are acetoacetate (AcAc) and 3-beta-hydroxybutyrate (3HB), while acetone is the third, and least abundant, ketone body. Ketones are always present in the blood and their levels increase during fasting and prolonged exercise. They are also found in the blood of neonates and pregnant women. Diabetes is the most common pathological cause of elevated blood ketones. In diabetic ketoacidosis (DKA), high levels of ketones are produced in response to low insulin levels and high levels of counterregulatory hormones. In acute DKA, the ketone body ratio (3HB : AcAc) rises from normal (1 : 1) to as high as 10 : 1. In response to insulin therapy, 3HB levels commonly decrease long before AcAc levels. The frequently employed nitroprusside test only detects AcAc in blood and urine. This test is inconvenient, does not assess the best indicator of ketone body levels (3HB), provides only a semiquantitative assessment of ketone levels and is associated with false-positive results. Recently, inexpensive quantitative tests of 3HB levels have become available for use with small blood samples (5-25 mu l). These tests offer new options for monitoring and treating diabetes and other states characterized by the abnormal metabolism of ketone bodies. Copyright (C) 1999 John Wiley & Sons, Ltd.
引用
收藏
页码:412 / 426
页数:15
相关论文
共 144 条
[1]   ALCOHOLIC KETOACIDOSIS [J].
ADAMS, SL ;
MATHEWS, JJ ;
FLAHERTY, JJ .
ANNALS OF EMERGENCY MEDICINE, 1987, 16 (01) :90-97
[2]   The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients [J].
Ahmed, ABE ;
Home, PD .
DIABETES CARE, 1998, 21 (01) :32-37
[3]  
*AM DIAB ASS, 1992, DIABETES CARE, V15, pS38
[4]  
Amer Diabet Assoc, 1999, DIABETES CARE, V22, pS77
[5]   UNRECOGNIZED ADULT SALICYLATE INTOXICATION [J].
ANDERSON, RJ ;
POTTS, DE ;
GABOW, PA ;
RUMACK, BH ;
SCHRIER, RW .
ANNALS OF INTERNAL MEDICINE, 1976, 85 (06) :745-748
[6]  
[Anonymous], 1994, DIABETES CARE, V17, P616
[7]  
ARTUCH R, 1995, EUR J CLIN CHEM CLIN, V33, P529
[8]  
Atkins RC, 1973, DR ATKINS DIET REVOL
[9]   KETONE-BODY PRODUCTION AND DISPOSAL - EFFECTS OF FASTING, DIABETES, AND EXERCISE [J].
BALASSE, EO ;
FERY, F .
DIABETES-METABOLISM REVIEWS, 1989, 5 (03) :247-270
[10]   BLOOD LACTATE AND KETONE-BODY CONCENTRATIONS IN SALICYLATE INTOXICATION [J].
BARTELS, PD ;
LUNDJACOBSEN, H .
HUMAN TOXICOLOGY, 1986, 5 (06) :363-366